相似文献
1
Long-term remission of disseminated parathyroid cancer following immunotherapy.
Endocrine. 2020 Jan;67(1):204-208. doi: 10.1007/s12020-019-02136-z. Epub 2019 Nov 28.
2
Parathyroid cancer.
Semin Oncol. 2010 Dec;37(6):580-90. doi: 10.1053/j.seminoncol.2010.10.013.
3
Microsatellite instability driven metastatic parathyroid carcinoma managed with the anti-PD1 immunotherapy, pembrolizumab.
BMJ Case Rep. 2020 Sep 23;13(9):e235293. doi: 10.1136/bcr-2020-235293.
4
Concurrence of primary hyperparathyroidism and metastatic breast carcinoma affected a parathyroid gland.
J Clin Endocrinol Metab. 2013 Aug;98(8):3127-30. doi: 10.1210/jc.2013-1227. Epub 2013 Jun 7.
5
Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages.
Surgery. 2018 Nov;164(5):960-964. doi: 10.1016/j.surg.2018.06.013. Epub 2018 Jul 20.
6
Parathyroid carcinoma: Challenges in diagnosis and treatment.
Ann Endocrinol (Paris). 2015 May;76(2):169-77. doi: 10.1016/j.ando.2015.03.003. Epub 2015 Apr 21.
7
Nonfunctional parathyroid carcinoma.
J Natl Med Assoc. 2001 Jul-Aug;93(7-8):251-5.
8
Parathyroid Carcinoma: Diagnosis and Clinical Implications.
Turk Patoloji Derg. 2015;31 Suppl 1:80-97. doi: 10.5146/tjpath.2015.01316.
9
Clinicopathological correlates of hyperparathyroidism.
J Clin Pathol. 2015 Oct;68(10):771-87. doi: 10.1136/jclinpath-2015-203186. Epub 2015 Jul 10.
10
Chapter 8: Management of aggressive forms of primary HPT: Parathyroid carcinoma and atypical parathyroid tumor.
Ann Endocrinol (Paris). 2025 Feb;86(1):101697. doi: 10.1016/j.ando.2025.101697. Epub 2025 Jan 14.
引用本文的文献
1
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes.
Endocr Rev. 2025 Jul 15;46(4):576-620. doi: 10.1210/endrev/bnaf010.
2
Unusual presentation and management of parathyroid carcinoma with pulmonary metastasis: a case report.
AME Case Rep. 2024 Oct 11;9:4. doi: 10.21037/acr-24-94. eCollection 2025.
3
Metastatic parathyroid carcinoma diagnosed after five surgical attempts: a case report and review of the literature.
J Cardiothorac Surg. 2024 Dec 4;19(1):642. doi: 10.1186/s13019-024-03146-3.
4
Refractory Hypercalcemia Secondary to Metastatic Parathyroid Carcinoma Treated With Immunotherapy.
JCEM Case Rep. 2024 Jul 15;2(7):luae127. doi: 10.1210/jcemcr/luae127. eCollection 2024 Jul.
5
Parathyroid Carcinoma Presenting as Recurrent Primary Hyperparathyroidism and Neck Mass: A Case Report.
touchREV Endocrinol. 2023 Jul;19(2):80-85. doi: 10.17925/EE.2023.19.2.6. Epub 2023 Jul 11.
6
Molecular and Clinical Spectrum of Primary Hyperparathyroidism.
Endocr Rev. 2023 Sep 15;44(5):779-818. doi: 10.1210/endrev/bnad009.
7
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases.
Front Oncol. 2022 Sep 26;12:997009. doi: 10.3389/fonc.2022.997009. eCollection 2022.
8
Parathyroid Carcinoma: Incidence, Survival Analysis, and Management: A Study from the SEER Database and Insights into Future Therapeutic Perspectives.
Cancers (Basel). 2022 Mar 10;14(6):1426. doi: 10.3390/cancers14061426.
9
Mortality factors in recurrent parathyroid cancer: a pooled analysis.
J Bone Miner Metab. 2022 May;40(3):508-517. doi: 10.1007/s00774-021-01305-3. Epub 2022 Feb 20.
10
Exploring the potential biomarkers for prognosis of glioblastoma via weighted gene co-expression network analysis.
PeerJ. 2022 Jan 18;10:e12768. doi: 10.7717/peerj.12768. eCollection 2022.
本文引用的文献
1
Comprehensive Genomic Characterization of Parathyroid Cancer Identifies Novel Candidate Driver Mutations and Core Pathways.
J Endocr Soc. 2018 Sep 3;3(3):544-559. doi: 10.1210/js.2018-00043. eCollection 2019 Mar 1.
2
Parathyroid carcinoma.
Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):877-889. doi: 10.1016/j.beem.2018.11.002. Epub 2018 Dec 1.
3
Molecular genetic insights into sporadic primary hyperparathyroidism.
Endocr Relat Cancer. 2019 Feb 1;26(2):R53-R72. doi: 10.1530/ERC-18-0304.
4
Immune Checkpoint Inhibitor-Induced Hypoparathyroidism Associated With Calcium-Sensing Receptor-Activating Autoantibodies.
J Clin Endocrinol Metab. 2019 Feb 1;104(2):550-556. doi: 10.1210/jc.2018-01151.
5
Diagnosis and treatment challenges of parathyroid carcinoma in a 27-year-old woman with multiple lung metastases.
Endocrinol Diabetes Metab Case Rep. 2017 Mar 13;2017. doi: 10.1530/EDM-16-0113. eCollection 2017.
6
Cinacalcet hydrochloride relieves hypercalcemia in Japanese patients with parathyroid cancer and intractable primary hyperparathyroidism.
J Bone Miner Metab. 2017 Nov;35(6):616-622. doi: 10.1007/s00774-016-0797-0. Epub 2016 Nov 21.
7
Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB).
Ann Surg Oncol. 2015 Nov;22(12):3990-5. doi: 10.1245/s10434-015-4672-3. Epub 2015 Jun 16.
8
Parathyroid carcinoma: Challenges in diagnosis and treatment.
Ann Endocrinol (Paris). 2015 May;76(2):169-77. doi: 10.1016/j.ando.2015.03.003. Epub 2015 Apr 21.
9
Parathyroid carcinoma in more than 1,000 patients: A population-level analysis.
Surgery. 2014 Dec;156(6):1622-9; discussion 1629-30. doi: 10.1016/j.surg.2014.08.069. Epub 2014 Nov 11.
10
Parathyroid carcinoma: a 43-year outcome and survival analysis.
J Clin Endocrinol Metab. 2011 Dec;96(12):3679-86. doi: 10.1210/jc.2011-1571. Epub 2011 Sep 21.
Zotero 插件